These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17976508)

  • 1. Detection of mutant protein in complex biological samples: glucocerebrosidase mutations in Gaucher's disease.
    Bleijlevens B; van Breemen MJ; Donker-Koopman WE; de Koster CG; Aerts JM
    Anal Biochem; 2008 Jan; 372(1):52-61. PubMed ID: 17976508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I Gaucher's disease with homozygous R463C mutation without neurological involvement.
    Bolaman Z; Kadikoylu G; Levi E; Barutca S; Temucin K
    Haematologia (Budap); 2002; 32(4):487-93. PubMed ID: 12803123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
    Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y; Bartfeld D; Hashmueli S; Baum G; Brill-Almon E; Galili G; Dym O; Boldin-Adamsky SA; Silman I; Sussman JL; Futerman AH; Aviezer D
    Plant Biotechnol J; 2007 Sep; 5(5):579-90. PubMed ID: 17524049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.
    Wang F; Agnello G; Sotolongo N; Segatori L
    ACS Chem Biol; 2011 Feb; 6(2):158-68. PubMed ID: 21043486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher's disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase.
    Wang F; Chou A; Segatori L
    Chem Biol; 2011 Jun; 18(6):766-76. PubMed ID: 21700212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
    Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P; Pampín S; Estrada J; Rodríguez-Rey JC; Giraldo P; Sancho J; Pocoví M
    Blood Cells Mol Dis; 2005; 35(2):268-76. PubMed ID: 16039881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel frameshift mutation (Pro171fsX21) in neonatal type 2 Gaucher's disease.
    Park HW; Lee Y; Kim GH; Lee BS; Kim KS; Yoo HW; Kim EA
    Gene; 2012 Oct; 507(2):170-3. PubMed ID: 22772462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetics of Gaucher's disease. Genotype-phenotype correlation].
    Alfonso Palacín P; Pocoví M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():17-22. PubMed ID: 22230121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants.
    Sawkar AR; Schmitz M; Zimmer KP; Reczek D; Edmunds T; Balch WE; Kelly JW
    ACS Chem Biol; 2006 May; 1(4):235-51. PubMed ID: 17163678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype.
    Church HJ; Cooper A; Stewart F; Thornton CM; Wraith JE
    Eur J Hum Genet; 2004 Nov; 12(11):975-8. PubMed ID: 15292921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease: advances and challenges.
    Martin BM; Sidransky E; Ginns EI
    Adv Pediatr; 1989; 36():277-306. PubMed ID: 2675571
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of glucocerebrosidase and the treatment of Gaucher disease.
    Barranger JA; Tomich J; Weiler S; Sakallah S; Sansieri C; Mifflin T; Bahnson A; Wei FS; Wei JF; Vallor M
    Cytokines Mol Ther; 1995 Sep; 1(3):149-63. PubMed ID: 9384672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
    Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
    Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
    Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
    Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.